(Circulation. 1999;99:1416-1421.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
Mechanisms of Death in the CABG Patch Trial
A Randomized Trial of Implantable Cardiac Defibrillator Prophylaxis in Patients at High Risk of Death After Coronary Artery Bypass Graft Surgery
From Columbia University (J.T.B., W.W., P.B.N., R.C.S.), New York, NY; Vanderbilt University School of Medicine (J.N.R.), Nashville, Tenn; Washington University School of Medicine (R.E.K.), St Louis, Mo; Allegheny University Medical Center (C.D.G.), Philadelphia, Pa; and New England Medical Center (N.A.M.E.), Boston, Mass.
Correspondence to J. Thomas Bigger, Jr, MD, The CABG Patch Trial Data Coordinating Center, Columbia University, PH 103-D, 630 W 168th St, New York, NY 10032. E-mail jtb2{at}columbia.edu
Background—The CABG Patch trial compared prophylactic implantable cardiac-defibrillator (ICD) implantation with no antiarrhythmic therapy in coronary bypass surgery patients who had a left ventricular ejection fraction <0.36 and an abnormal signal-averaged ECG. There were 102 deaths among the 446 ICD group patients and 96 deaths among the 454 control group patients, a hazard ratio of 1.07 (P=0.63). The mechanisms of death were classified, and hypotheses were tested about the effects of ICD therapy on arrhythmic and nonarrhythmic cardiac deaths in the CABG Patch Trial and the Multicenter Automatic Defibrillator Implantation Trial (MADIT).
Methods and Results—The 198 deaths in the trial were reviewed by an independent Events Committee and classified by the method of Hinkle and Thaler. Only 54 deaths (27%) occurred out of hospital; 145 deaths (73%) were witnessed. Seventy-nine (82%) of the 96 deaths in the control group and 76 (75%) of the 102 deaths in the ICD group were due to cardiac causes. Cumulative arrhythmic mortality at 42 months was 6.9% in the control group and 4.0% in the ICD group (P=0.057). Cumulative nonarrhythmic cardiac mortality at 42 months was 12.4% in the control group and 13.0% in the ICD group (P=0.275). Death due to pump failure was significantly associated with death >1 hour from the onset of symptoms, dyspnea within 7 days of death, and overt heart failure within 7 days of death.
Conclusions—In the CABG Patch Trial, ICD therapy reduced arrhythmic death 45% without significant effect on nonarrhythmic deaths. Because 71% of the deaths were nonarrhythmic, total mortality was not significantly reduced.
Key Words: trials • heart-assist device • bypass
This article has been cited by other articles:
 |
|
 |
|
  J. J. Goldberger, M. E. Cain, S. H. Hohnloser, A. H. Kadish, B. P. Knight, M. S. Lauer, B. J. Maron, R. L. Page, R. S. Passman, D. Siscovick, et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention Circulation, September 30, 2008; 118(14): 1497 - 1518. [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Mangi Invited Commentary Ann. Thorac. Surg., April 1, 2008; 85(4): 1281 - 1282. [Full Text] [PDF]
|
|
|
|
 |
|
 I. Goldenberg, A. K. Vyas, W. J. Hall, A. J. Moss, H. Wang, H. He, W. Zareba, S. McNitt, M. L. Andrews, and for the MADIT-II Investigators Risk Stratification for Primary Implantation of a Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction J. Am. Coll. Cardiol., January 22, 2008; 51(3): 288 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Mozaffarian, S. D. Anker, I. Anand, D. T. Linker, M. D. Sullivan, J. G.F. Cleland, P. E. Carson, A. P. Maggioni, D. L. Mann, B. Pitt, et al. Prediction of Mode of Death in Heart Failure: The Seattle Heart Failure Model Circulation, July 24, 2007; 116(4): 392 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Goldenberg, A. J. Moss, W. J. Hall, S. McNitt, W. Zareba, M. L. Andrews, D. S. Cannom, and for the Multicenter Automatic Defibrillator Implan Causes and Consequences of Heart Failure After Prophylactic Implantation of a Defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II Circulation, June 20, 2006; 113(24): 2810 - 2817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Goldenberg, A. J. Moss, S. McNitt, W. Zareba, W. J. Hall, M. L. Andrews, D. J. Wilber, H. U. Klein, and for the MADIT-II Investigators Time Dependence of Defibrillator Benefit After Coronary Revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1811 - 1817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fernandes, J.-C. Amirault, G. Lande, J.-M. Nguyen, V. Forest, O. Bignolais, G. Lamirault, D. Heudes, J.-L. Orsonneau, M.-F. Heymann, et al. Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias Cardiovasc Res, February 1, 2006; 69(2): 348 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. O. O'Neill, R. C. Starling, Y. Khaykin, P. M. McCarthy, J. B. Young, M. Hail, N. M. Albert, N. Smedira, and M. K. Chung Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1250 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pascale, P. Taffe, C. Regamey, L. Kappenberger, and M. Fromer Reduced Ejection Fraction After Myocardial Infarction: Is It Sufficient To Justify Implantation of a Defibrillator? Chest, October 1, 2005; 128(4): 2626 - 2632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Gillis Prophylactic Implantable Cardioverter-Defibrillators after Myocardial Infarction -- Not for Everyone N. Engl. J. Med., December 9, 2004; 351(24): 2540 - 2542. [Full Text] [PDF]
|
|
|
|
|
|
H. Greenberg, R. B. Case, A. J. Moss, M. W. Brown, E. R. Carroll, M. L. Andrews, and MADIT-II Investigators Analysis of mortality events in the multicenter automatic defibrillator implantation trial (MADIT-II) J. Am. Coll. Cardiol., April 21, 2004; 43(8): 1459 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. DiMarco Implantable Cardioverter-Defibrillators N. Engl. J. Med., November 6, 2003; 349(19): 1836 - 1847. [Full Text] [PDF]
|
|
|
|
|
|
P. Menasche, A. A. Hagege, J.-T. Vilquin, M. Desnos, E. Abergel, B. Pouzet, A. Bel, S. Sarateanu, M. Scorsin, K. Schwartz, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction J. Am. Coll. Cardiol., April 2, 2003; 41(7): 1078 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Jessup The less familiar face of heart failure J. Am. Coll. Cardiol., January 15, 2003; 41(2): 224 - 226. [Full Text] [PDF]
|
|
|
|
|
|
A. A. Mangi, T. J. Boeve, G. J. Vlahakes, C. W. Akins, A. D. Hilgenberg, J. N. Ruskin, B. M. McGovern, and D. F. Torchiana Surgical coronary revascularization and antiarrhythmic therapy in survivors of out-of-hospital cardiac arrest Ann. Thorac. Surg., November 1, 2002; 74(5): 1510 - 1516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. de Lorgeril, P. Salen, P. Defaye, P. Mabo, and F. Paillard Dietary prevention of sudden cardiac death Eur. Heart J., February 2, 2002; 23(4): 277 - 285. [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Sanders, M. A. Hlatky, N. R. Every, K. M. McDonald, P. A. Heidenreich, L. S. Parsons, and D. K. Owens Potential Cost-Effectiveness of Prophylactic Use of the Implantable Cardioverter Defibrillator or Amiodarone after Myocardial Infarction Ann Intern Med, November 20, 2001; 135(10): 870 - 883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Scharf, H. Redecker, F. Duru, R. Candinas, H. P. Brunner-La Rocca, A. Gerber, O. Bertel, M. I. Turina, and W. Kiowski Sudden cardiac death after coronary artery bypass grafting is not predicted by signal-averaged ECG Ann. Thorac. Surg., November 1, 2001; 72(5): 1546 - 1551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. S. Weintraub Revascularization Versus Implantable Cardioverter-Defibrillators to Prevent Sudden Death in Patients With Severe Left Ventricular Dysfunction Circulation, September 25, 2001; 104(13): 1457 - 1458. [Full Text] [PDF]
|
|
|
|
|
|
G. D. Veenhuyzen, S. N. Singh, D. McAreavey, B. J. Shelton, and D. V. Exner Prior Coronary Artery Bypass Surgery and Risk of Death Among Patients With Ischemic Left Ventricular Dysfunction Circulation, September 25, 2001; 104(13): 1489 - 1493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. V. Exner, G. J. Klein, and E. N. Prystowsky Primary Prevention of Sudden Death With Implantable Defibrillator Therapy in Patients With Cardiac Disease: Can We Afford to Do It? (Can We Afford Not To?) Circulation, September 25, 2001; 104(13): 1564 - 1570. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Gomes, M. E. Cain, A. E. Buxton, M. E. Josephson, K. L. Lee, and G. E. Hafley Prediction of Long-Term Outcomes by Signal-Averaged Electrocardiography in Patients With Unsustained Ventricular Tachycardia, Coronary Artery Disease, and Left Ventricular Dysfunction Circulation, July 24, 2001; 104(4): 436 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. DiMarco Is programmed stimulation in survivors of myocardial infarction helpful? J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1908 - 1909. [Full Text] [PDF]
|
|
|
|
|
|
R. J Myerburg and P. M Spooner Opportunities for sudden death prevention: Directions for new clinical and basic research Cardiovasc Res, May 1, 2001; 50(2): 177 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Whang, J. T. Bigger Jr., and The CABG Patch Trial Investigators and Coordinator Diabetes and outcomes of coronary artery bypass graft surgery in patients with severe left ventricular dysfunction: results from The CABG Patch Trial database J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1166 - 1172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Implantable Defibrillators May Not Help High-Risk Bypass Patients Journal Watch (General), April 6, 1999; 1999(406): 7 - 7. [Full Text]
|
|
|
|
|
|
J. T. Bigger Expanding Indications for Implantable Cardiac Defibrillators N. Engl. J. Med., March 21, 2002; 346(12): 931 - 933. [Full Text] [PDF]
|
|